HealthQuill Exercises
Eli Lilly and Company’s Zepbound or trizepatide injection to treat obesity reduces the risk of heart failure, hospitalisation and cardiovascular death by 38%, according to a statement from the Indianapolis-headquartered firm.
Drugs Health Pharma

Eli Lilly’s trial weight-loss drug reduces heart failure risk by 38%

Eli Lilly and Company’s Zepbound or trizepatide injection to treat obesity reduces the risk of heart failure, hospitalisation and cardiovascular death by 38%,.

Read More
Exposure to bright lights before sleep can induce gestational diabetes mellitus in pregnant women, a study by Northwestern Medicine, an affiliate of Northwestern University Feinberg School of Medicine in Chicago, found.
Health Medical

Dim lights hours before sleep to avoid gestational diabetes mellitus

Exposure to bright lights before sleep can induce gestational diabetes mellitus in pregnant women, a study by Northwestern Medicine, an affiliate of Northwestern.

Read More
Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the condition by 84%.
Drugs Medical Pharma

Merck says trial hypertension drug enhances patients’ walk time

Merck announced its experimental trial on patients with pulmonary arterial hypertension had led to an extension in walking distance and reduced exacerbating the.

Read More